Prevalence of Deep Vein Thrombosis in Patients With Cervical Cancer.
- 1Obstetrics and Gynaecology, Post Graduate Institute of Medical Education and Research, Chandigarh, IND.
- 2Radiotherapy, Post Graduate Institute of Medical Education and Research, Chandigarh, IND.
- 3Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, IND.
Abstract
Background Deep vein thrombosis (DVT) is a life-threatening complication that occurs in patients with cervical cancer. The purpose of the study was to determine the prevalence of DVT in patients with cervical cancer at recruitment and to assess clinically suspected DVT during treatment and up to four months after completion of primary treatment. Methods The study was performed at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. Fifty-three histopathologically proven patients with cervical cancer were taken for ultrasound (compression and Doppler) at recruitment. Patients were then followed up during treatment and until four months after completion of primary treatment to monitor for any clinical signs or symptoms of DVT. Results Out of 53 patients evaluated, no cases of DVT were identified among patients with cervical cancer at recruitment on compression and Doppler ultrasound, during treatment, and until four months after completion of primary treatment, based on clinical features. A negative report could result from the small number of patients studied; most were at an early stage (stage II) and may have led to a false-negative result. Additionally, none of the patients had clear cell carcinoma, and only 16 (30.18%) patients were in advanced stages (III and IV) based on radiological evaluation. Conclusions DVT was not observed in patients with cervical cancer during the study period. These findings suggest that the prevalence of DVT may be low in this population. However, they should be interpreted cautiously given the limited sample size and the absence of routine follow-up imaging. Larger prospective studies are needed to further evaluate the risk of DVT in patients with cervical cancer.
Related
- Anxiety in patients with lower-extremity deep vein thrombosis: a patient-centred sequential explanatory mixed-methods study of prevalence, associated factors, and patient experiences
- AngioJet rheolytic thrombectomy under superior vena cava filter protection for acute upper extremity deep vein thrombosis in patients with cancer: a single-center, retrospective analysis
- CO012 | LONG-TERM RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN ADULT PATIENTS WITH ACTIVE CANCER AND FIRST CATHETER-RELATED UPPER EXTREMITY DEEP VEIN THROMBOSIS AFTER DISCONTINUATION OF ANTICOAGULANT TREATMENTS AND LINE REMOVAL: A RETROSPECTIVE MULTI-CENTER COHORT STUDY – CANCER-CRT STUDY
- Association between delayed thromboprophylaxis and the incidence of deep vein thrombosis in patients with pelvic trauma: a retrospective cohort adjusted for severity at a level I trauma center
- Anticoagulant Prophylaxis with Edoxaban for Asymptomatic Isolated Distal Deep Vein Thrombosis in Perioperative Hip Fracture Patients.
BibTeX
@article{yadav2026prevalence,
title = {{Prevalence of Deep Vein Thrombosis in Patients With Cervical Cancer.}},
author = {Krishna Kumar Yadav and G R V Prasad and Bhavana Rai and Arun Sharma},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116617},
url = {https://europepmc.org/article/MED/42909209},
note = {CC BY},
}
RIS
TY - JOUR
TI - Prevalence of Deep Vein Thrombosis in Patients With Cervical Cancer.
AU - Krishna Kumar Yadav
AU - G R V Prasad
AU - Bhavana Rai
AU - Arun Sharma
PY - 2026
DA - 2026/09/20
JO - Cureus
DO - 10.7759/cureus.116617
UR - https://europepmc.org/article/MED/42909209
AB - Background Deep vein thrombosis (DVT) is a life-threatening complication that occurs in patients with cervical cancer. The purpose of the study was to determine the prevalence of DVT in patients with cervical cancer at recruitment and to assess clinically suspected DVT during treatment and up to four months after completion of primary treatment. Methods The study was performed at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. Fifty-three histopathologically proven patients with cervical cancer were taken for ultrasound (compression and Doppler) at recruitment. Patients were then followed up during treatment and until four months after completion of primary treatment to monitor for any clinical signs or symptoms of DVT. Results Out of 53 patients evaluated, no cases of DVT were identified among patients with cervical cancer at recruitment on compression and Doppler ultrasound, during treatment, and until four months after completion of primary treatment, based on clinical features. A negative report could result from the small number of patients studied; most were at an early stage (stage II) and may have led to a false-negative result. Additionally, none of the patients had clear cell carcinoma, and only 16 (30.18%) patients were in advanced stages (III and IV) based on radiological evaluation. Conclusions DVT was not observed in patients with cervical cancer during the study period. These findings suggest that the prevalence of DVT may be low in this population. However, they should be interpreted cautiously given the limited sample size and the absence of routine follow-up imaging. Larger prospective studies are needed to further evaluate the risk of DVT in patients with cervical cancer.
SN - 2168-8184
ER -